Name
The Future of the Endocrine Disruptor Screening Program
Date & Time
Tuesday, April 16, 2024, 2:00 PM - 3:00 PM
Speakers
Description
EPA is working to meet its obligations and commitments to screen for endocrine disrupting effects in humans and EPA released near-term strategies for implementation of the Endocrine Disruptor Screening Program (EDSP). This session will discuss the strategy documents, other EPA initiatives around EDSP, future plans, and industry advancements in the area.
Location Name
Studio D
Full Address
Renaissance Arlington Capital View Hotel
2800 S Potomac Ave
Arlington, VA 22202
United States
2800 S Potomac Ave
Arlington, VA 22202
United States
Session Type
Concurrent Session